Vermont biologics regulations.
Who may administer PRP, exosomes and stem cells in Vermont, and which agencies to check.

Who may administer biologics in Vermont?
In Vermont, stem cell and biologic therapies are typically administered by licensed healthcare professionals, such as physicians (MDs/DOs), or physician assistants, and nurse practitioners under supervision. These professionals must hold valid Vermont licenses and meet state certification standards for administering such therapies.
Official sources
Vermont compliance guide.
FDA Compliance
While Vermont does not have biologics-specific regulations beyond federal FDA requirements, the Vermont Department of Health provides valuable resources and standards for healthcare practitioners. Clinics should familiarize themselves with Vermont’s general healthcare practice standards to ensure compliance and alignment with state expectations.
Staying updated with both federal FDA standards and state health guidelines will support comprehensive compliance efforts in Vermont.
Provider Qualifications
In Vermont, stem cell and biologic therapies are typically administered by licensed healthcare professionals, such as physicians (MDs/DOs), or physician assistants, and nurse practitioners under supervision. These professionals must hold valid Vermont licenses and meet state certification standards for administering such therapies.
For current licensing requirements and any recent changes, consult the Vermont Office of Professional Regulation.
Patient Informed Consent
Vermont clinics are required to provide patients with comprehensive informed consent prior to biologic treatments. The consent should cover:
- A clear explanation of the procedure and its purpose
- Risks and potential benefits
- Possible alternatives to the treatment
- The experimental or investigational nature of biologic therapies, where applicable
Pre-Treatment and Post-Treatment Protocols
Developing standardized pre-treatment and post-treatment protocols helps maintain consistency in care and safety for patients. It is advisable for clinics to implement SOPs for evaluating patient eligibility, administering the treatment, and providing post-treatment care to ensure optimal outcomes and patient satisfaction.
Insurance Requirements
Clinics should verify that their medical liability insurance policy includes coverage for biologic therapies. Confirming this coverage with your provider helps mitigate potential legal and financial risks.
Marketing Compliance
Marketing of biologic therapies must comply with FDA and Vermont advertising standards. Avoid misleading claims, unverified benefits, or unsupported language in promotions. All promotional materials should be accurate, transparent, and include appropriate disclaimers regarding the experimental status of some biologic treatments.
This guide is a general summary to help clinics understand compliance requirements for biologics in Vermont. It is not legal advice. Regulations change; consult legal counsel and the agencies above before acting on it.
Vermont: common questions.
Who can administer stem cells, PRP and exosomes in Vermont?
Are stem cell and exosome therapies FDA-approved in Vermont?
Do I need an IRB-approved study to offer biologics in Vermont?
How do I start offering biologics in Vermont?
Practising in Vermont? Start with the webinar.
Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.